Protagenic Therapeutics Stock Volatility
| PTIXW Stock | USD 0.01 0 11.11% |
Protagenic Therapeutics is out of control given 3 months investment horizon. Protagenic Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.22, which implies the firm had a 0.22% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 57.67% are justified by taking the suggested risk. Use Protagenic Therapeutics Coefficient Of Variation of 2271.48, risk adjusted performance of 0.0434, and Semi Deviation of 18.39 to evaluate company specific risk that cannot be diversified away. Key indicators related to Protagenic Therapeutics' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Protagenic Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Protagenic daily returns, and it is calculated using variance and standard deviation. We also use Protagenic's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Protagenic Therapeutics volatility.
Protagenic |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Protagenic Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Protagenic Therapeutics at lower prices. For example, an investor can purchase Protagenic stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Protagenic Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Protagenic Stock
Moving against Protagenic Stock
Protagenic Therapeutics Market Sensitivity And Downside Risk
Protagenic Therapeutics' beta coefficient measures the volatility of Protagenic stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Protagenic stock's returns against your selected market. In other words, Protagenic Therapeutics's beta of -2.97 provides an investor with an approximation of how much risk Protagenic Therapeutics stock can potentially add to one of your existing portfolios. Protagenic Therapeutics is showing large volatility of returns over the selected time horizon. Protagenic Therapeutics is a penny stock. Even though Protagenic Therapeutics may be a good instrument to invest, many penny stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Protagenic Therapeutics or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Protagenic instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Protagenic Therapeutics Demand TrendCheck current 90 days Protagenic Therapeutics correlation with market (Dow Jones Industrial)Protagenic Beta |
Protagenic standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 262.9 |
It is essential to understand the difference between upside risk (as represented by Protagenic Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Protagenic Therapeutics' daily returns or price. Since the actual investment returns on holding a position in protagenic stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Protagenic Therapeutics.
Protagenic Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Protagenic Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Protagenic Therapeutics' price changes. Investors will then calculate the volatility of Protagenic Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Protagenic Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Protagenic Therapeutics' fluctuations based on previous trends. It's commonly used to predict Protagenic Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Protagenic Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Protagenic Therapeutics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Protagenic Therapeutics Projected Return Density Against Market
Assuming the 90 days horizon Protagenic Therapeutics has a beta of -2.9714 indicating as returns on its benchmark rise, returns on holding Protagenic Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Protagenic Therapeutics is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Protagenic Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Protagenic Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Protagenic stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Protagenic Therapeutics has an alpha of 1.6116, implying that it can generate a 1.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Protagenic Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Protagenic Therapeutics Stock Risk Measures
Assuming the 90 days horizon the coefficient of variation of Protagenic Therapeutics is 455.86. The daily returns are distributed with a variance of 69116.66 and standard deviation of 262.9. The mean deviation of Protagenic Therapeutics is currently at 126.45. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | 1.61 | |
β | Beta against Dow Jones | -2.97 | |
σ | Overall volatility | 262.90 | |
Ir | Information ratio | 0.04 |
Protagenic Therapeutics Stock Return Volatility
Protagenic Therapeutics historical daily return volatility represents how much of Protagenic Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The venture shows 262.9005% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7736% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Protagenic Therapeutics Volatility
Volatility is a rate at which the price of Protagenic Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Protagenic Therapeutics may increase or decrease. In other words, similar to Protagenic's beta indicator, it measures the risk of Protagenic Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Protagenic Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 25.4 K | 24.1 K | |
| Market Cap | 4.9 M | 4.7 M |
Protagenic Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Protagenic Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Protagenic Therapeutics' price varies over time.
3 ways to utilize Protagenic Therapeutics' volatility to invest better
Higher Protagenic Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Protagenic Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Protagenic Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Protagenic Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Protagenic Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Protagenic Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Protagenic Therapeutics Investment Opportunity
Protagenic Therapeutics has a volatility of 262.9 and is 341.43 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Protagenic Therapeutics is higher than 96 percent of all global equities and portfolios over the last 90 days. You can use Protagenic Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Protagenic Therapeutics to be traded at $0.0076 in 90 days.Good diversification
The correlation between Protagenic Therapeutics and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Protagenic Therapeutics Additional Risk Indicators
The analysis of Protagenic Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Protagenic Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Protagenic Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0434 | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 17.68 | |||
| Semi Deviation | 18.39 | |||
| Downside Deviation | 25.8 | |||
| Coefficient Of Variation | 2271.48 | |||
| Standard Deviation | 28.83 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Protagenic Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Protagenic Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Protagenic Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Protagenic Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Protagenic Therapeutics.
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.